The Journal of Immunology, Vol 150, Issue 12 5476-5483, Copyright © 1993 by American Association of Immunologists

ARTICLES

Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major

TM Doherty and RL Coffman
Department of Immunology, DNAX Research Institute for Cellular and Molecular Biology, Palo Alto, CA 94304.

Leishmania major, a causative agent of leishmaniasis, in humans is also capable of infecting mice. Several strains of mice, including the BALB/c strain, are unable to mount appropriate T cell responses to the parasite and develop a fatal, disseminated infection. We present evidence that injection of granulocyte-macrophage-CSF derived bone marrow macrophages (GMM phi), previously incubated with L. major antigens, into BALB/c mice before infection, induced a Th1-dominated response and subsequent healing. Injection of BALB/c mice with GMM phi pulsed with irrelevant Ag, or other macrophages pulsed with L. major Ag, failed to protect against L. major challenge. Protection induced by L. major Ag-bearing GMM phi correlated with the induction of a Th1-like response with the production of high levels of IFN-gamma, delayed-type hypersensitivity reactivity and long-lived resistance to reinfection. GMM phi-T cell interaction, rather than parasite killing by GMM phi, appeared to be a crucial step and there was a strong correlation between ability to function as APC in vitro and induction of protective immunity in vivo. These data suggest that presentation of Ag by a population of L. major Ag-bearing GMM phi can activate Th1 cells in BALB/c mice, leading to a protective immune response to parasite invasion. This implies that the nature of the APC population which presents Ag may influence the response to that Ag in vivo.

This article has been cited by other articles:

				P. Scott, H. Ma, S. Viriyakosol, R. Terkeltaub, and R. Liu-Bryan Engagement of CD14 Mediates the Inflammatory Potential of Monosodium Urate Crystals J. Immunol., November 1, 2006; 177(9): 6370 - 6378. [Abstract] [Full Text] [PDF]

				R. P. ALMEIDA, J. BRITO, P. L. MACHADO, A. R. DE JESUS, A. SCHRIEFER, L. H. GUIMARAES, and E. M. CARVALHO SUCCESSFUL TREATMENT OF REFRACTORY CUTANEOUS LEISHMANIASIS WITH GM-CSF AND ANTIMONIALS Am J Trop Med Hyg, July 1, 2005; 73(1): 79 - 81. [Abstract] [Full Text] [PDF]

				M. P. Lemos, F. Esquivel, P. Scott, and T. M. Laufer MHC Class II Expression Restricted to CD8{alpha}+ and CD11b+ Dendritic Cells Is Sufficient for Control of Leishmania major J. Exp. Med., March 1, 2004; 199(5): 725 - 730. [Abstract] [Full Text] [PDF]

				C. Dumas, A. Muyombwe, G. Roy, C. Matte, M. Ouellette, M. Olivier, and B. Papadopoulou Recombinant Leishmania major Secreting Biologically Active Granulocyte-Macrophage Colony-Stimulating Factor Survives Poorly in Macrophages In Vitro and Delays Disease Development in Mice Infect. Immun., November 1, 2003; 71(11): 6499 - 6509. [Abstract] [Full Text] [PDF]

				M. A. P. Oliveira, G. M. A. C. Lima, M. T. Shio, P. J. M. Leenen, and I. A. Abrahamsohn Immature macrophages derived from mouse bone marrow produce large amounts of IL-12p40 after LPS stimulation J. Leukoc. Biol., November 1, 2003; 74(5): 857 - 867. [Abstract] [Full Text] [PDF]

				E. Kuroda and U. Yamashita Mechanisms of Enhanced Macrophage-Mediated Prostaglandin E2 Production and Its Suppressive Role in Th1 Activation in Th2-Dominant BALB/c Mice J. Immunol., January 15, 2003; 170(2): 757 - 764. [Abstract] [Full Text] [PDF]

				E. Kuroda, T. Kito, and U. Yamashita Reduced Expression of STAT4 and IFN-{gamma} in Macrophages from BALB/c Mice J. Immunol., June 1, 2002; 168(11): 5477 - 5482. [Abstract] [Full Text] [PDF]

				M. A. Marovich, M. A. McDowell, E. K. Thomas, and T. B. Nutman IL-12p70 Production by Leishmania major-Harboring Human Dendritic Cells Is a CD40/CD40 Ligand-Dependent Process J. Immunol., June 1, 2000; 164(11): 5858 - 5865. [Abstract] [Full Text] [PDF]

				N. A. Giese, L. Gabriele, T. M. Doherty, D. M. Klinman, L. Tadesse-Heath, C. Contursi, S. L. Epstein, and H. C. Morse III Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression J. Exp. Med., November 3, 1997; 186(9): 1535 - 1546. [Abstract] [Full Text] [PDF]

				E. Gemmell and G. J. Seymour Cytokines and T Cell Switching Critical Reviews in Oral Biology & Medicine, January 1, 1994; 5(3): 249 - 279. [Abstract] [Full Text] [PDF]